Private biotech 2004--the numbers.

Hodgson, John · Nat Biotechnol · 2006

editorial · Level V

Where this comes from

Abstract

Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.

Medical subject headings